These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 9031440)

  • 21. Localization of components from the plasminogen activation system in mammalian tissues.
    Kristensen P
    APMIS Suppl; 1992; 29():1-27. PubMed ID: 1337257
    [No Abstract]   [Full Text] [Related]  

  • 22. Bacterial plasminogen receptors utilize host plasminogen system for effective invasion and dissemination.
    Bhattacharya S; Ploplis VA; Castellino FJ
    J Biomed Biotechnol; 2012; 2012():482096. PubMed ID: 23118509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of macrophage receptor-bound plasmin by autoproteolysis.
    Falcone DJ; Borth W; McCaffrey TA; Mathew J; McAdam K
    J Biol Chem; 1994 Dec; 269(51):32660-6. PubMed ID: 7528219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of plasmin(ogen) acquisition by clinical isolates of group A streptococci incubated in human plasma.
    Wang H; Lottenberg R; Boyle MD
    J Infect Dis; 1994 Jan; 169(1):143-9. PubMed ID: 8277175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.
    Webb CP; Hose CD; Koochekpour S; Jeffers M; Oskarsson M; Sausville E; Monks A; Vande Woude GF
    Cancer Res; 2000 Jan; 60(2):342-9. PubMed ID: 10667586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasminogen activator expression and matrix degradation.
    Rifkin DB
    Matrix Suppl; 1992; 1():20-2. PubMed ID: 1480022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
    Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
    Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of activator on the esterase activity of plasmin obtained by streptokinase].
    Potron G; Droulle-Bertignon C; Ledoyen MP
    C R Seances Soc Biol Fil; 1975; 169(4):1029-33. PubMed ID: 2372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Receptors for human plasminogen on the biological response modifier OK-432.
    Ullberg M; Tewodros W; Kronvall G
    J Biol Response Mod; 1990 Dec; 9(6):592-6. PubMed ID: 1963635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulation of cell surface plasminogen activation by membrane-bound melanotransferrin: a key phenomenon for cell invasion.
    Michaud-Levesque J; Demeule M; Béliveau R
    Exp Cell Res; 2005 Aug; 308(2):479-90. PubMed ID: 15936756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inactivation of the streptokinase gene prevents Streptococcus equisimilis H46A from acquiring cell-associated plasmin activity in the presence of plasminogen.
    Malke H; Mechold U; Gase K; Gerlach D
    FEMS Microbiol Lett; 1994 Feb; 116(1):107-12. PubMed ID: 8132150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasminogen activator and plasmin-like activities in experimental rat tumours.
    Tözsér J; Hamvas A; Rády P; Kertai P; Elödi P
    Acta Biochim Biophys Hung; 1989; 24(1-2):119-28. PubMed ID: 2558473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of plasminogen/plasmin receptors on human glomerular epithelial cells.
    Becquemont L; Nguyen G; Peraldi MN; He CJ; Sraer JD; Rondeau E
    Am J Physiol; 1994 Aug; 267(2 Pt 2):F303-10. PubMed ID: 7520669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacterial plasminogen receptors: in vitro evidence for a role in degradation of the mammalian extracellular matrix.
    Lähteenmäki K; Virkola R; Pouttu R; Kuusela P; Kukkonen M; Korhonen TK
    Infect Immun; 1995 Sep; 63(9):3659-64. PubMed ID: 7642304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A role for fibrinogen in the streptokinase-dependent acquisition of plasmin(ogen) by group A streptococci.
    Wang H; Lottenberg R; Boyle MD
    J Infect Dis; 1995 Jan; 171(1):85-92. PubMed ID: 7798686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of staphylokinase in the acquisition of plasmin(ogen)-dependent enzymatic activity by staphylococci.
    Christner RB; Boyle MD
    J Infect Dis; 1996 Jan; 173(1):104-12. PubMed ID: 8537646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parasitism in optima forma: exploiting the host fibrinolytic system for invasion.
    Figuera L; Gómez-Arreaza A; Avilán L
    Acta Trop; 2013 Oct; 128(1):116-23. PubMed ID: 23850506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Streptokinase-plasmin(ogen) activator assays.
    Radek JT; Davidson DJ; Castellino FJ
    Methods Enzymol; 1993; 223():145-55. PubMed ID: 8271949
    [No Abstract]   [Full Text] [Related]  

  • 39. Cell-induced potentiation of the plasminogen activation system is abolished by a monoclonal antibody that recognizes the NH2-terminal domain of the urokinase receptor.
    Rønne E; Behrendt N; Ellis V; Ploug M; Danø K; Høyer-Hansen G
    FEBS Lett; 1991 Aug; 288(1-2):233-6. PubMed ID: 1715292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Follicular plasminogen and plasminogen activator and the effect of plasmin on ovarian follicle wall.
    Beers WH
    Cell; 1975 Nov; 6(3):379-86. PubMed ID: 151588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.